BusPIRone Hydrochloride Tablets, USP 7.5 mg NDC# 49884-725-01
Par Pharmaceutical
Failed Impurity /Degradation Specifications
💊 Drugs • 12,141 recalls
Par Pharmaceutical
Failed Impurity /Degradation Specifications
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
Cross Contamination with other products: trace amounts of lidocaine
BAYSHORE PHARMACEUTICALS
CGMP Deviations
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
Microbial contamination of Non-Sterile Product; detection of the gram-negative bacillus Serratia marcescens in certain API batches
Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).
Sub-potent Drug: Out-of-Specification assay results found at 3 month stability testing.
Labeling; Not Elsewhere Classified: The Mentholatum Company is initiating a voluntary recall due to an error in the labeling of the cotton pellet box found within the Red Cross Oral Pain blister pack. The cotton pellet box states that the product contains "Natural Eugenol Oil" in which it does not.
Hetero Labs Limited (Unit V)
Failed Tablet/Capsule Specification; complaint of bulging tablet
BAYSHORE PHARMACEUTICALS
CGMP Deviations
Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.
Calvin Scott & Company
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Calvin Scott & Company
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Ferring Pharmaceuticals
Superpotent Drug
Ferring Pharmaceuticals
Superpotent Drug
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Calvin Scott & Company
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.